Short report: Malaria drug shortages in kenya: A major failure to provide access to effective treatment

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 737-738

  Kangwana, Beth B ^{a,b,c,d,e,f,g}   Njogu, Julius ^{a,b,c,d,e,f,g}   Wasunna, Beatrice ^{a,b,c,d,e,f,g}   Kedenge, Sarah V ^{a,b,c,d,e,f,g}   Memusi, Dorothy N ^{a,b,c,d,e,f,g}   Goodman, Catherine A ^{a,b,c,d,e,f,g}   Zurovac, Dejan ^{a,b,c,d,e,f,g}   Snow, Robert W ^{a,b,c,d,e,f,g}  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Kenya Red Cross   (Kenya)

^c MINISTRY OF HEALTH   (Kenya)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Center for International Health and Development   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMETHER LUMEFANTRINE COMBINATION; ARTEMETHER-LUMEFANTRINE COMBINATION; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ARTICLE; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; ENDEMIC DISEASE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HUMAN; KENYA; MALARIA; PRESCRIPTION; THERAPY DELAY; TREATMENT FAILURE; DRUG COMBINATION; DRUG PACKAGING; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; INTERNATIONAL COOPERATION; PUBLIC HEALTH SERVICE; STANDARD;

ANTIMALARIALS; ARTEMISININS; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG PACKAGING; ETHANOLAMINES; FLUORENES; GOVERNMENT REGULATION; HEALTH FACILITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; KENYA; MALARIA; PUBLIC HEALTH ADMINISTRATION;

EID: 66149103229     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.737     Document Type: Article

References (10)

1. Talisuna AO, Bloland P, D'Alessandro U, 2004. History, dynamics and public health importance of malaria parasite resistance. Clin Microbiol Rev 17: 235-254.
2. Attaran A, Barnes KI, Curtis C, D'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM, 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363: 237-240.
3. World Health Organization, 2006. Guidelines for the Treatment of Malaria. Global Malaria Programme. Geneva: World Health Organization, WHO/HTM/MAL/2006:1108.
4. Bosman A, Mendis KN, 2007. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg 77 (Suppl 6): 193-197.
5. Shretta R, Omumbo J, Rapuoda BA, Snow RW, 2000. Using evi-dence to change antimalarial drug policy in Kenya. Trop Med Int Health 5: 755-764.
6. Williams HA, Durrheim DN, Shretta R, 2004. The process of changing national malaria treatment policy: lessons from coun-try level studies. Health Policy Plan 19: 356-370.
7. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW, 2007. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J 6: 72.
8. Njogu J, Akhwale W, Hamer DH, Zurovac D, 2008. Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya. East Afr Med J 85: 213-221.
9. Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda R Hamer DH, Simon JL, Snow RW, 2007. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sec-tional study. Malar J 6: 31.
10. Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW, 2008. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J 7:181.